BacteriologyBiofilm prevention concentrations (BPC) of minocycline compared to Polymyxin B (cas 1404-26-8), meropenem, and amikacin against Acinetobacter baumannii

Add time:09/02/2019    Source:sciencedirect.com

Infections caused by Acinetobacter baumannii are difficult to treat as they are often multidrug resistant (MDR) and frequently form biofilms. We investigated the activities of minocycline, polymyxin B, meropenem, and amikacin against diverse Acinetobacter baumannii strains with biofilm formation classified as weak versus moderate/strong. At clinically achievable concentrations, minocycline prevented biofilm formation for 96% of isolates versus 54% for polymyxin B, 29% for meropenem and 29% for amikacin. Minocycline and polymyxin B demonstrated highest in vitro activity against A. baumannii and prevented biofilm formation for a majority of isolates.

We also recommend Trading Suppliers and Manufacturers of Polymyxin B (cas 1404-26-8). Pls Click Website Link as below: cas 1404-26-8 suppliers

Prev:Polymyxin B (cas 1404-26-8) and polymyxin E induce anaphylactoid response through mediation of Mas-related G protein–coupled receptor X2
Next:Co-delivery of buparvaquone and Polymyxin B (cas 1404-26-8) in nanostructured lipid carrier for leishmaniasis treatment)